Curemark
Pre-clinicalCuremark develops novel therapies for neurological disorders, focusing on neurotransmitter deficiencies and related conditions.
Founded
2003
Focus
Small Molecules
About
Curemark develops novel therapies for neurological disorders, focusing on neurotransmitter deficiencies and related conditions.
Funding History
3Total raised: $41.5M
Grant$1.5MNational Institutes of HealthJun 15, 2015
Series B$15MUndisclosedJun 15, 2010
Series A$25MUndisclosedJun 15, 2007
Company Info
TypePrivate
Founded2003
LocationRye, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile